# ADVIL ALLERGY AND CONGESTION RELIEF
> **NDA022113** · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 2011-12-21
## Drug
- **FDA Application Number:** NDA022113
- **Application type:** New Drug Application
- **Brand name:** ADVIL ALLERGY AND CONGESTION RELIEF
- **Generic name:** CHLORPHENIRAMINE MALEATE, IBUPROFEN, AND PHENYLEPHRINE HYDROCHLORIDE
- **Active ingredients:** CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HALEON US HOLDINGS
- **Manufacturer:** Haleon US Holdings LLC
- **First approval:** 2011-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022113)
---
*MORVS · CC0 1.0*